MedPath
FDA Approval

IBANDRONATE SODIUM

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Alvogen Inc.
DUNS: 008057330
Effective Date
April 1, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Ibandronate(150 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

OrBion Pharmaceuticals Private Limited

Alvogen Inc.

OrBion Pharmaceuticals Private Limited

854403569

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

IBANDRONATE SODIUM

Product Details

NDC Product Code
47781-103
Application Number
ANDA078998
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 1, 2017
Code: J12U072QL0Class: ACTIMQuantity: 150 mg in 1 1
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94EClass: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
CROSPOVIDONE (120 .MU.M)Inactive
Code: 68401960MKClass: IACT
SODIUM STEARYL FUMARATEInactive
Code: 7CV7WJK4UIClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WOClass: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1AClass: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRTClass: IACT
© Copyright 2025. All Rights Reserved by MedPath